Mar 27, 2026
Alan Armstrong- Amount
- $1,001 to $15,000
- Filed
- Jul 21, 2026
Congress ticker disclosure profile
As of August 22 at 2:06 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference FIX. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
25
Member filers
4
Disclosed ranges
$24K
Most active member desks
23 buys vs 2 sells
Latest trade Mar 27, 2026
Mar 27, 2026
Alan ArmstrongDec 4, 2025
Byron DonaldsJan 13, 2025
Rob BresnahanMar 30, 2020
Michael T. McCaulMar 16, 2020
Michael T. McCaulMar 15, 2020
Michael T. McCaulMar 13, 2020
Michael T. McCaulMar 12, 2020
Michael T. McCaulMar 9, 2020
Michael T. McCaulMar 6, 2020
Michael T. McCaulFeb 28, 2020
Michael T. McCaulFeb 27, 2020
Michael T. McCaulFeb 26, 2020
Michael T. McCaulFeb 25, 2020
Michael T. McCaulFeb 24, 2020
Michael T. McCaulFeb 21, 2020
Michael T. McCaulFeb 20, 2020
Michael T. McCaulFeb 19, 2020
Michael T. McCaulFeb 18, 2020
Michael T. McCaulFeb 14, 2020
Michael T. McCaulFeb 13, 2020
Michael T. McCaulFeb 12, 2020
Michael T. McCaulFeb 11, 2020
Michael T. McCaulFeb 10, 2020
Michael T. McCaulFeb 7, 2020
Michael T. McCaul| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Mar 27, 2026 | Alan Armstrong | Buy | $1,001 to $15,000 | Jul 21, 2026 | Open card |
| Dec 4, 2025 | Byron Donalds | Buy | $1,001 to $15,000 | Jan 7, 2026 | Open card |
| Jan 13, 2025 | Rob Bresnahan | Sell | $1,001 to $15,000 | Feb 13, 2025 | Open card |
| Mar 30, 2020 | Michael T. McCaul | Sell | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 16, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 15, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 13, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 12, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 9, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 6, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 28, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 27, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 20, 2020 | Open card |
| Feb 26, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 25, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 24, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 20, 2020 | Open card |
| Feb 21, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 20, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 20, 2020 | Open card |
| Feb 19, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 18, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 14, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 13, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 20, 2020 | Open card |
| Feb 12, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 20, 2020 | Open card |
| Feb 11, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Feb 10, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 20, 2020 | Open card |
| Feb 7, 2020 | Michael T. McCaul | Buy | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 3 of 25 filed rows include disclosed amount ranges (12%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.